Cargando…
Hepatocellular Carcinoma in Pakistan: Where do We Stand?
CONTEXT: From the 1970s till the mid 1990s, hepatitis B was the most common etiological factor for hepatocellular carcinoma (HCC) in Pakistan. Afterwards, a shift in HCC etiology was observed with a steady rise in hepatitis C virus (HCV) related HCC cases. HCV-3a, which is the most prevalent genotyp...
Autores principales: | Butt, Amna Subhan, Abbas, Zaigham, Jafri, Wasim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500772/ https://www.ncbi.nlm.nih.gov/pubmed/23166534 http://dx.doi.org/10.5812/hepatmon.6023 |
Ejemplares similares
-
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
por: Russo, Francesco Paolo, et al.
Publicado: (2022) -
Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?
por: Bartolotta, Tommaso Vincenzo, et al.
Publicado: (2019) -
Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019) -
Hepatocellular Carcinoma (HCC), Where do we stand? Current situation
por: Hafeez, Muhammad, et al.
Publicado: (2020) -
ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)